Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07431827
PHASE3

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

This is a phase 3, randomized, double-blind study of adjuvant calderasib plus subcutaneous pembrolizumab and berahyaluronidase alfa (MK-3475A) versus adjuvant placebo plus MK-3475a in participants with completely resected stage IIA-IIIB (N2), KRAS G12C-mutant non-small cell lung cancer following receipt of either neoadjuvant pembrolizumab plus chemotherapy or adjuvant chemotherapy. The primary goal of the study is to compare adjuvant calderasib plus MK-3475A to adjuvant placebo plus MK-3475A with respect to disease-free survival (DFS) as assessed by the investigator.

Official title: A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2026-03-18

Completion Date

2039-10-26

Last Updated

2026-11-02

Healthy Volunteers

No

Interventions

DRUG

Calderasib

MK-1084 oral tablet

BIOLOGICAL

MK-3475A

Fixed dose coformulated product of hyaluronidase/pembrolizumab administered via SC injection.

DRUG

Placebo

Placebo oral tablet

Locations (120)

Instituto Alexander Fleming ( Site 0310)

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Sanatorio Parque ( Site 0311)

Rosario, Santa Fe Province, Argentina

Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0306)

CABA, Argentina

Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0309)

CABA, Argentina

Northern Beaches Hospital ( Site 3009)

Frenchs Forest, New South Wales, Australia

Princess Alexandra Hospital ( Site 3012)

Woolloongabba, Queensland, Australia

Peninsula University Hospital ( Site 3011)

Frankston, Victoria, Australia

PRONUTRIR ( Site 0425)

Fortaleza, Ceará, Brazil

AFECC ASSOCIACAO FEMININA EDUCACAO COMBATE CANCER ( Site 0414)

Vitória, Espírito Santo, Brazil

Hospital Madre Teresa ( Site 0420)

Belo Horizonte, Minas Gerais, Brazil

Real Hospital Portugues ( Site 0418)

Recife, Pernambuco, Brazil

Faculdade de Medicina do ABC ( Site 0415)

Santo André, São Paulo, Brazil

Instituto do Câncer Brasil - Unidade Taubaté ( Site 0424)

Taubaté, São Paulo, Brazil

Hospital Alemao Oswaldo Cruz ( Site 0416)

São Paulo, Brazil

Moncton Hospital ( Site 0200)

Moncton, New Brunswick, Canada

CIUSSS- saguenay-Lac-Saint-Jean ( Site 0216)

Chicoutimi, Quebec, Canada

Centre Hospitalier de l'Université de Montréal ( Site 0219)

Montreal, Quebec, Canada

Clínica MEDS La Dehesa ( Site 0509)

Lo Barnechea, Region M. de Santiago, Chile

Fundación Arturo López Pérez ( Site 0501)

Santiago, Region M. de Santiago, Chile

Centro de Oncología de Precisión ( Site 0503)

Santiago, Region M. de Santiago, Chile

Bradford Hill ( Site 0508)

Santiago, Region M. de Santiago, Chile

Peking University People's Hospital ( Site 2100)

Beijing, Beijing Municipality, China

Beijing Cancer hospital ( Site 2106)

Beijing, Beijing Municipality, China

Peking Union Medical College Hospital ( Site 2105)

Beijing, Beijing Municipality, China

Chongqing University Three Gorges Hospital ( Site 2138)

Chongqing, Chongqing Municipality, China

The First Affiliated Hospital Of Fujian Medical University ( Site 2123)

Fuzhou, Fujian, China

Fujian Cancer Hospital ( Site 2122)

Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center ( Site 2134)

Guangzhou, Guangdong, China

Guangxi Medical University Cancer Hospital ( Site 2115)

Nanning, Guangxi, China

Fourth Hospital Of Hebei Medical University ( Site 2107)

Hshijiazhuang, Hebei, China

Tongji Hospital Tongji Medical,Science & Technology ( Site 2140)

Wuhan, Hubei, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 2139)

Wuhan, Hubei, China

Xiangya Hospital Central South University ( Site 2136)

Changsha, Hunan, China

Hunan Cancer Hospital ( Site 2112)

Changsha, Hunan, China

The First Affiliated Hospital of Nanchang University ( Site 2121)

Nanchang, Jiangxi, China

Affiliated Cancer Hospital of Shandong First Medical University ( Site 2111)

Jinan, Shandong, China

Shanghai Pulmonary Hospital ( Site 2125)

Shanghai, Shanghai Municipality, China

Fudan University Shanghai Cancer Center ( Site 2137)

Shanghai, Shanghai Municipality, China

Zhongshan Hospital of Fudan University ( Site 2119)

Shanghai, Shanghai Municipality, China

West China Hospital, Sichuan University ( Site 2142)

Chengdu, Sichuan, China

The Third Peoples Hospital Of Chengdu ( Site 2141)

Chengdu, Sichuan, China

Sichuan Cancer hospital ( Site 2101)

Chengdu, Sichuan, China

The Affiliated Cancer Hospital of Xinjiang Medical ( Site 2110)

Urumuqi, Xinjiang, China

Yunnan Province Cancer Hospital ( Site 2131)

Kunming, Yunnan, China

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 2118)

Hangzhou, Zhejiang, China

The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 2103)

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital ( Site 2117)

Hangzhou, Zhejiang, China

Ningbo No. 2 Hospital ( Site 2124)

Ningbo, Zhejiang, China

Promotora Médica Las Américas S.A. ( Site 0602)

Medellín, Antioquia, Colombia

Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0603)

Bogotá, Bogota D.C., Colombia

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0601)

Bogota, Cundinamarca, Colombia

Instituto Médico de Alta Tecnología S.A.S. ( Site 0605)

Montería, Departamento de Córdoba, Colombia

Oncologos Del Occidente ( Site 0606)

Pereira, Risaralda Department, Colombia

Hopital Nord ( Site 1004)

Marseille, Bouches-du-Rhone, France

Centre François Baclesse ( Site 1017)

Caen, Calvados, France

Centre de Cancérologie du Grand Montpellier ( Site 1016)

Montpellier, Languedoc-Roussillon, France

Centre Hospitalier Intercommunal ( Site 1019)

Créteil, Val-de-Marne, France

Evangelismos General Hospital of Athens ( Site 1204)

Athens, Attica, Greece

Errikos Dunant Hospital Center ( Site 1201)

Athens, Attica, Greece

THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 1206)

Athens, Attica, Greece

Athens Medical Center ( Site 1202)

Athens, Attica, Greece

Metaxa Cancer Hospital of Piraeus ( Site 1207)

Piraeus, Attica, Greece

G. Papanikolaou General Hospital ( Site 1203)

Thessaloniki, Central Macedonia, Greece

Queen Mary Hospital ( Site 3100)

Hong Kong, Hong Kong

Tuen Mun Hospital ( Site 3102)

Hong Kong, Hong Kong

Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1400)

Milan, Lombardy, Italy

IEO Istituto Europeo di Oncologia ( Site 1405)

Milan, Lombardy, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1401)

Roma, Italy

Hirosaki University Hospital ( Site 2200)

Hirosaki, Aomori, Japan

Hospital of the University of Occupational and Environmental Health, Japan ( Site 2214)

Kitakyushu, Fukuoka, Japan

Fukushima Medical University Hospital ( Site 2202)

Fukushima, Japan

Yamagata University Hospital ( Site 2201)

Yamagata, Japan

Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1607)

Przemyśl, Podkarpackie Voivodeship, Poland

National Cancer Center ( Site 3603)

Goyang-si, Kyonggi-do, South Korea

The Catholic University of Korea St. Vincent s Hospital ( Site 3602)

Suwon, Kyonggi-do, South Korea

Keimyung University Dongsan Hospital ( Site 3605)

Daegu, Taegu-Kwangyokshi, South Korea

Severance Hospital Yonsei University Health System ( Site 3601)

Seoul, South Korea

Asan Medical Center ( Site 3600)

Seoul, South Korea

Hospital Insular de Gran Canaria ( Site 1704)

Las Palmas de Gran Canaria, Canary Islands, Spain

Institut Català d'Oncologia (ICO) - Girona ( Site 1703)

Girona, Gerona, Spain

Hospital Puerta de Hierro ( Site 1705)

Majadahonda, Madrid, Spain

Hospital Universitari Vall d'Hebron ( Site 1700)

Barcelona, Spain

Hospital Clinico San Carlos ( Site 1706)

Madrid, Spain

Hospital Universitario la Paz ( Site 1710)

Madrid, Spain

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1707)

Madrid, Spain

H.R.U Malaga - Hospital General ( Site 1708)

Málaga, Spain

Hospital Universitario Virgen Macarena ( Site 1709)

Seville, Spain

Taipei Medical University Shuang Ho Hospital ( Site 3700)

New Taipei City, Taiwan

National Cheng Kung University Hospital ( Site 3706)

Tainan, Taiwan

Mackay Memorial Hospital ( Site 3701)

Taipei, Taiwan

National Taiwan University Cancer Center (NTUCC) ( Site 3707)

Taipei, Taiwan

Tri-Service General Hospital ( Site 3708)

Taipei, Taiwan

Baskent University Dr. Turgut Noyan Research and Training Center ( Site 1812)

Adana, Turkey (Türkiye)

Adana Medical Park Seyhan Hastanesi ( Site 1827)

Adana, Turkey (Türkiye)

Ankara Atatürk Sanatoryum Eğitim ve Araştırma Hastanesi ( Site 1825)

Ankara, Turkey (Türkiye)

Hacettepe Universite Hastaneleri ( Site 1810)

Ankara, Turkey (Türkiye)

Ankara Bilkent Şehir Hastanesi ( Site 1811)

Ankara, Turkey (Türkiye)

Liv Hospital Ankara ( Site 1828)

Ankara, Turkey (Türkiye)

Kartal Lütfi Kırdar Şehir Hastanesi ( Site 1826)

Istanbul, Turkey (Türkiye)

İnönü Üniversitesi Turgut Özal Tıp Merkezi ( Site 1815)

Malatya, Turkey (Türkiye)

And 20 more locations on ClinicalTrials.gov